Search results for " therapeutic"
Article
Biosimilars Development and Supply: How Complex Can the Process Be?
High-quality, reliably supplied biosimilars offer additional therapeutic choices to patients and other key stakeholders; however, development and supply of these complex medicines are scientifically c…
Article
The Development and Application of a Monoclonal Antibody Purification Platform
The platform was developed to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies. The success of this p…
Article
Optimizing KiH bispecific antibody chromatography steps
Bispecific antibodies (bsAbs) are a promising class of therapeutic agents due to their ability to bind to two different types of antigens or two different epitopes on the same antigen. This a…
Article
Introducing the VH3 ligand ELISA kit
Ensuring the safety and efficacy of antibody-based therapeutics is crucial in biotherapeutic manufacturing. Accurate testing for ligand leakage from affinity resins is a key part of this proce…
Article
Get Started: Purification of mAb Variants - eLearning
The success of monoclonal antibodies (mAbs) as therapeutics and the multi-domain structure of antibodies has made it possible to create antibody variants, such as bispecific antibodies (bsAbs)…
Article
Exploring the world of antibodies: mAbs, Fabs, dAbs, and bsAbs
Learn more about developing purification protocols for the diversified therapeutic antibody pipelines.
READ ARTICLE
Article
Report from the 6th International HTPD Conference
In 2023 it was facilitated by Michael Doherty from Ring Therapeutics, and the panel members were: Felix Wittkopp, (Roche), David Smithson (Seagen), John Welsh (Rivanna Bioprocess Solutions), Cornelia …
Article
Ready for a strong start in oligo manufacturing?
Are you interested in manufacturing your own oligonucleotide therapeutics but don’t know how to start? Or are you already manufacturing your own oligos but are running into challenges? If so, …
Webcast
Biotech Makers: Solving challenges in process development of a diversifying antibody pipeline
The therapeutic pipeline for antibodies continues to diversify into new modalities including bi-specific, tri-specific, antibody fragments and domain antibodies which bring new challenges to process…
Article
BetaLife Wins Cytiva's First BioChallenge Competition in Southeast Asia
Southeast Asia BioChallenge received applications from companies with interests in four different therapeutic areas. BetaLife was named as the winner of the first BioChallenge in Southeast A…